RANKL immunisation inhibits prostate cancer metastasis by modulating EMT through a RANKL-dependent pathway
Abstract Prostate cancer (PCa) morbidity in the majority of patients is due to metastatic events, which are a clinical obstacle. Therefore, a better understanding of the mechanism underlying metastasis is imperative if we are to develop novel therapeutic strategies. Receptor activator of nuclear fac...
Enregistré dans:
| Auteurs principaux: | , , , , , , , |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
Nature Portfolio
2021
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/af65c06b2e6b4f5390c60c729a4c4302 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|